Dietmar Hopp (Malte Ossowski/SVEN SIMON/picture-alliance/dpa/AP Images)
Billionaire Dietmar Hopp steers his secretive Covid-19 biotech player to Nasdaq following major pact with GSK
One of the most secretive biotech candidates to lead the development of a new mRNA vaccine to fight Covid-19 just filed their IPO papers for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
